Destination Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Destination Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$483K	Buy	917 +120	+15%	+$67.3K	0.01%	222
2026 Q1	$448K	Buy	797 +23	+3%	+$14.7K	0.01%	218
2025 Q4	$524K	Sell	774 -23	-3%	-$15.7K	0.01%	193
2025 Q3	$509K	Buy	797 +12	+2%	+$7.28K	0.01%	179
2025 Q2	$421K	Buy	785 +4	+0.5%	+$1.91K	0.01%	191
2025 Q1	$328K	Buy	781 +8	+1%	+$3.47K	0.01%	198
2024 Q4	$320K	Buy	+773	New	+$339K	0.01%	194
2019 Q2	–	Sell	-3	Closed	-$1K	–	644
2019 Q1	$1K	Buy	+3	New	+$619	﹤0.01%	635
2018 Q2	–	Sell	-14	Closed	-$3K	–	578
2018 Q1	$3K	Buy	+14	New	+$2.58K	﹤0.01%	482

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Destination Wealth Management's IDXX Position: Q2 2026 in Review

Destination Wealth Management increased its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, buying an estimated $67.3K and bringing the position to 917 shares worth $483K. The position accounts for 0.01% of the portfolio, ranked #222.

Destination Wealth Management first reported a position in IDXX in Q1 2018 and has held it in 9 quarters since. The position peaked at $524K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Destination Wealth Management held 917 shares of Idexx Laboratories worth $483K as of Q2 2026.
Destination Wealth Management bought 120 Idexx Laboratories shares in Q2 2026, an estimated $67.3K.
Idexx Laboratories made up 0.01% of Destination Wealth Management's portfolio in Q2 2026, its #222 holding.
Destination Wealth Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 9 quarters since.
Destination Wealth Management's Idexx Laboratories position peaked at $524K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Destination Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.